Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bioventus Inc.BVS · Entity 4996 | SVP & Chief Compliance Officer | April 10, 2026 | April 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bioventus Inc.
Report date April 10, 2026 · Filed April 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 64,164 |
Ending reported balance
After 2026-04-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-04-10 · Exercise / conversion · Acquired 4,300 · Balance 66,032 Row 2 · 2026-04-10 · Tax withholding · Disposed 1,868 · Balance 64,164 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,300 |
Reported balance
After 2026-04-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-10 · Exercise / conversion · Disposed 4,300 · Balance 4,300 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2: The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2: The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2022 Filed Apr 21, 2023 21:33 UTC | Bioventus Inc. BVS · Entity 4996 | SaleClass A Common Stock | 58 | $7.00 | $406.00 |
DisclosureSEC source: 0001578563-23-000025 · primary_doc.xml · nonDerivative · entry 3 CHURCH KATRINA J · CIK 0001204391 · SVP & Chief Compliance Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,222 F1 · kind: Reflects shares sold to cover taxes in connection with shares purchased under the Company's 2021 Employee Stock Purchase Plan. Read SEC document |
| October 03, 2022 Filed Jun 9, 2023 00:05 UTC Amendment | Bioventus Inc. BVS · Entity 4996 | SaleClass A Common Stock | 58 | $7.00 | $406.00 |
DisclosureSEC source: 0001578563-23-000044 · primary_doc.xml · nonDerivative · entry 3 CHURCH KATRINA J · CIK 0001204391 · SVP & Chief Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,222 F1 · kind: Reflects shares sold to cover taxes in connection with purchases made under the Company's 2021 Employee Stock Purchase Plan and a Rule 10b5-1 instruction in place at the time of such purchases. Read SEC document |
| July 01, 2022 Filed Apr 21, 2023 21:33 UTC | Bioventus Inc. BVS · Entity 4996 | SaleClass A Common Stock | 58 | $6.73 | $390.34 |
DisclosureSEC source: 0001578563-23-000025 · primary_doc.xml · nonDerivative · entry 2 CHURCH KATRINA J · CIK 0001204391 · SVP & Chief Compliance Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,280 F1 · kind: Reflects shares sold to cover taxes in connection with shares purchased under the Company's 2021 Employee Stock Purchase Plan. Read SEC document |
| July 01, 2022 Filed Jun 9, 2023 00:05 UTC Amendment | Bioventus Inc. BVS · Entity 4996 | SaleClass A Common Stock | 58 | $6.73 | $390.34 |
DisclosureSEC source: 0001578563-23-000044 · primary_doc.xml · nonDerivative · entry 2 CHURCH KATRINA J · CIK 0001204391 · SVP & Chief Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,280 F1 · kind: Reflects shares sold to cover taxes in connection with purchases made under the Company's 2021 Employee Stock Purchase Plan and a Rule 10b5-1 instruction in place at the time of such purchases. Read SEC document |
| April 01, 2022 Filed Apr 21, 2023 21:33 UTC | Bioventus Inc. BVS · Entity 4996 | SaleClass A Common Stock | 15 | $14.07 | $211.05 |
DisclosureSEC source: 0001578563-23-000025 · primary_doc.xml · nonDerivative · entry 1 CHURCH KATRINA J · CIK 0001204391 · SVP & Chief Compliance Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,338 F1 · kind: Reflects shares sold to cover taxes in connection with shares purchased under the Company's 2021 Employee Stock Purchase Plan. Read SEC document |
| April 01, 2022 Filed Jun 9, 2023 00:05 UTC Amendment | Bioventus Inc. BVS · Entity 4996 | SaleClass A Common Stock | 15 | $14.07 | $211.05 |
DisclosureSEC source: 0001578563-23-000044 · primary_doc.xml · nonDerivative · entry 1 CHURCH KATRINA J · CIK 0001204391 · SVP & Chief Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,338 F1 · kind: Reflects shares sold to cover taxes in connection with purchases made under the Company's 2021 Employee Stock Purchase Plan and a Rule 10b5-1 instruction in place at the time of such purchases. Read SEC document |
| March 14, 2022 Filed Mar 17, 2023 01:17 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionRestricted Stock Units · Derivative | 3,456 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-008788 · doc4.xml · derivative · entry 4 CHURCH KATRINA J · CIK 0001204391 · SVP & Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,367 Underlying: Class A Common Stock · 3,456 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The original grant of 13,823 RSUs vest in four approximately equal annual installments beginning on March 14, 2023. F4 · derivative.expiration_date: The original grant of 13,823 RSUs vest in four approximately equal annual installments beginning on March 14, 2023. Read SEC document |
| March 14, 2022 Filed Mar 17, 2023 01:17 UTC | Bioventus Inc. BVS · Entity 4996 | GrantRestricted Stock Units · Derivative | 13,823 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-008788 · doc4.xml · derivative · entry 3 CHURCH KATRINA J · CIK 0001204391 · SVP & Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,823 Underlying: Class A Common Stock · 13,823 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The original grant of 13,823 RSUs vest in four approximately equal annual installments beginning on March 14, 2023. F4 · derivative.expiration_date: The original grant of 13,823 RSUs vest in four approximately equal annual installments beginning on March 14, 2023. Read SEC document |
| March 14, 2022 Filed Apr 13, 2023 00:48 UTC | Bioventus Inc. BVS · Entity 4996 | GrantStock Option (Right to Buy) · Derivative | 37,385 | $0.00 Strike: $12.66 | $0.00 |
DisclosureSEC source: 0001578563-23-000019 · primary_doc.xml · derivative · entry 2 CHURCH KATRINA J · CIK 0001204391 · SVP & Chief Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,385 Underlying: Class A Common Stock · 37,385 shares Expires 2032-03-14 F1 · derivative.exercise_date: The options shall vest in four equal installments on each of the first four anniversaries of March 14, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date. Read SEC document |
| February 11, 2021 Filed Apr 5, 2021 20:30 UTC | Bioventus Inc. BVS · Entity 4996 | PurchaseCommon Stock | 2,500 | $13.00 | $32,500.00 |
DisclosureSEC source: 0000899243-21-014828 · doc4.xml · nonDerivative · entry 1 CHURCH KATRINA J · CIK 0001204391 · SVP & Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.